D’Achille et al., 2020 - Google Patents
Rare-earth-doped cerium oxide nanocubes for biomedical near-infrared and magnetic resonance imagingD’Achille et al., 2020
- Document ID
- 11822535393044162710
- Author
- D’Achille A
- Gonzalez-Rodriguez R
- Campbell E
- Lee B
- Coffer J
- Naumov A
- Publication year
- Publication venue
- ACS Biomaterials Science & Engineering
External Links
Snippet
Near-infrared (NIR) fluorescence provides a new avenue for biomedical fluorescence imaging that allows for the tracking of fluorophore through several centimeters of biological tissue. However, such fluorophores are rare and, due to accumulation-derived toxicity, are …
- OFJATJUUUCAKMK-UHFFFAOYSA-N Cerium(IV) oxide [O-2]=[Ce+4]=[O-2] 0 title abstract description 219
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
Publication | Publication Date | Title |
---|---|---|
D’Achille et al. | Rare-earth-doped cerium oxide nanocubes for biomedical near-infrared and magnetic resonance imaging | |
Zhou et al. | Biodegradable inorganic nanoparticles for cancer theranostics: insights into the degradation behavior | |
Tabish et al. | Biocompatibility and toxicity of graphene quantum dots for potential application in photodynamic therapy | |
Li et al. | Theranostic carbon dots with innovative NIR-II emission for in vivo renal-excreted optical imaging and photothermal therapy | |
Dai et al. | Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging-guided photothermal tumor ablation | |
Han et al. | Therapeutic mesopore construction on 2D Nb2C MXenes for targeted and enhanced chemo-photothermal cancer therapy in NIR-II biowindow | |
Sharma et al. | Advances in lung cancer treatment using nanomedicines | |
Zhao et al. | Near-infrared light-triggered lysosome-targetable carbon dots for photothermal therapy of cancer | |
Zhu et al. | Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy | |
Yang et al. | A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles | |
Nicolson et al. | DNA nanostructures and DNA‐functionalized nanoparticles for cancer theranostics | |
Guo et al. | A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity | |
Yang et al. | Multifunctional Bi@ PPy-PEG core–shell nanohybrids for dual-modal imaging and photothermal therapy | |
Xue et al. | Emerging functional nanomaterials for therapeutics | |
Liu et al. | Using plasmonic copper sulfide nanocrystals as smart light-driven sterilants | |
Gonçalves et al. | Nano‐graphene oxide: a potential multifunctional platform for cancer therapy | |
Santos et al. | Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications | |
Dong et al. | Multimode imaging-guided photothermal/chemodynamic synergistic therapy nanoagent with a tumor microenvironment responded effect | |
Yang | Upconversion nanophosphors for use in bioimaging, therapy, drug delivery and bioassays | |
Liu et al. | Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging | |
Yong et al. | Gadolinium polytungstate nanoclusters: a new theranostic with ultrasmall size and versatile properties for dual-modal MR/CT imaging and photothermal therapy/radiotherapy of cancer | |
Cui et al. | Renal clearable Ag nanodots for in vivo computer tomography imaging and photothermal therapy | |
Saha et al. | Surface-engineered multifunctional Eu: Gd2O3 nanoplates for targeted and pH-responsive drug delivery and imaging applications | |
Li et al. | A nanoscale photothermal agent based on a metal-organic coordination polymer as a drug-loading framework for effective combination therapy | |
Mukherjee et al. | Tunable luminescent carbon nanospheres with well‐defined nanoscale chemistry for synchronized imaging and therapy |